TrademarkDir
NANT CANCER VACCINE
LIVE

Serial Number

97800703

Owner

NANT HOLDINGS IP, LLC

Attorney

Michael J. McCue

First Use Date

Jul 19, 2022

Filing Date

Feb 17, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

NANT CANCER VACCINE Trademark

Serial Number: 97800703 • Registration: 7573522

NANT CANCER VACCINE is a trademark filed by NANT HOLDINGS IP, LLC on February 17, 2023. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

NANT HOLDINGS IP, LLC (233 trademarks)

11755 WILSHIRE BOULEVARD
LOS ANGELES, CA 90025

Entity Type: 16

Trademark Details

Filing Date

February 17, 2023

Registration Date

November 19, 2024

First Use Anywhere

July 19, 2022

First Use in Commerce

July 19, 2022

Published for Opposition

August 8, 2023

Goods & Services

medical services; medical information; providing a website featuring medical information in the fields of immunotherapy; providing a website featuring medical information in the fields of oncology, cancer, immuneoncology, autoimmune diseases, infectious diseases, human diseases, animal diseases, vaccines biologics, cells and cell-derived preparations; providing medical and health information relating to pharmaceuticals, oncology, cancer, immuneoncology, immunotherapy, autoimmune diseases, infectious diseases, human diseases, animal diseases, vaccines, biologics, cells, and cell-derived preparations

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 19, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 19, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 15, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 15, 2024 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 15, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 4, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 22, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 22, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 22, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 22, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Apr 22, 2024 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Apr 19, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 19, 2024 AITU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 3, 2024 EXRA
USE AMENDMENT FILED
Apr 1, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 1, 2024 EISU
SOU EXTENSION 1 GRANTED
Apr 1, 2024 EX1G
SOU EXTENSION 1 FILED
Apr 1, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 1, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 3, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 8, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 8, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 19, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 29, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 29, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 29, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 29, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 29, 2023 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 29, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 29, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 29, 2023 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 29, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 29, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 29, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 29, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 8, 2023 NWOS
NEW APPLICATION ENTERED
Feb 21, 2023 NWAP

Related Trademarks

More from this Owner

PATIENT LANGUAGE MODELS

PATIENT LANGUAGE MODELS

PATIENT LANGUAGE MODELS

PATIENT LANGUAGE MODELS

WIGIGLINK

WIGIGLINK

NANTAIRDROP

NANTAIRDROP

NANTAIRDROP

NANTAIRDROP

PULSENET

PULSENET